Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Soliton Inc (SOLY)

Soliton Inc (SOLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 212,375
  • Shares Outstanding, K 16,089
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,310 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 19.13

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.32 +39.73%
on 10/02/19
14.86 -2.96%
on 10/21/19
+1.09 (+8.18%)
since 09/20/19
3-Month
8.65 +66.71%
on 08/09/19
15.90 -9.31%
on 07/23/19
+2.34 (+19.37%)
since 07/19/19

Most Recent Stories

More News
Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 14.42 (+9.24%)
Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical technology company that has developed a new acoustic shockwave device, today announced that the Taiwan Intellectual Property Office...

SOLY : 14.42 (+9.24%)
Soliton Announces $6.25 Million Private Placement

Soliton, Inc. (NASDAQ: SOLY), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"),...

SOLY : 14.42 (+9.24%)
Biotech Brief: U.S. Medical Technology Market Projected To Exceed $200 Billion By 2023

Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases - trends that expand healthcare spending....

MHMNF : 54.5000 (unch)
SOLY : 14.42 (+9.24%)
AKCA : 18.94 (+4.76%)
LVGO : 20.00 (-3.01%)
PFNX : 9.26 (+0.11%)
GILD : 65.21 (+0.46%)
Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 14.42 (+9.24%)
Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor's Choice

Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 14.42 (+9.24%)
Soliton Completes Keloid POC Clinical Trial Treatments

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 14.42 (+9.24%)
Soliton Announces Majority of Patients Treated in Pivotal Cellulite Trial; Expects All Patients Treated by November 2019

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 14.42 (+9.24%)
Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 14.42 (+9.24%)
Soliton Completes Trial Enrollment and Conducts Initial Site Training to Start Keloid Trial

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 14.42 (+9.24%)
Trade SOLY with:

Business Summary

Soliton Inc. is a medical device company. Its commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. Soliton Inc. is based in Houston, Texas.

See More

Key Turning Points

2nd Resistance Point 15.68
1st Resistance Point 15.05
Last Price 14.42
1st Support Level 13.60
2nd Support Level 12.78

See More

52-Week High 29.00
Fibonacci 61.8% 19.50
Fibonacci 50% 16.56
Last Price 14.42
Fibonacci 38.2% 13.62
52-Week Low 4.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar